At Fundación Jesús Serra, we are firmly committed to maintaining the public's safety and health. An approach that, in the face of the health crisis resulting from Covid-19, is becoming more relevant than ever.
With the aim of vindicating the work of Spanish healthcare professionals, scientists and researchers and, as a result, ensuring that society's health problems are dealt with, we have donated €350,000 to the CSIC (Spanish National Research Council), which is one of the research groups leading several projects to protect the population from infection.
Specifically, this contribution is going to one of the research groups of the CSIC National Centre for Biotechnology (CNB). Since January, the CNB has been leading various projects aimed at a detailed understanding of the structure of this coronavirus, developing the appropriate vaccines and protecting against the infection.
In this context, diagnostic tests have proven to be a key technology for controlling the pandemic. For this reason, during the months of confinement, four groups of the CNB-CSIC have worked round the clock to develop a serological test that is expected to be available in Spanish hospitals within one and a half months. According to studies carried out in collaboration with the Immunology Services at La Princesa University Hospital and La Paz University Hospital, this test allows us to determine 98% immunity to Covid-19. This is crucial, since most of the people infected display very mild symptoms. The test will be produced by the Spanish company Immunostep, in the ELISA kit format; one of the most reliable technologies.